Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as ...

Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as ...

Biogen will invest an additional $2 billion in its existing manufacturing in North Carolina, the drugmaker said on Monday, as ...

The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will ...

Biogen has announced plans to invest an additional $2bn in Research Triangle Park (RTP) in the US state of North Carolina.

Shares of biotech company Biogen (NASDAQ:BIIB) fell 3.1% in the morning session after analysts at Truist downgraded the stock ...

Biogen will invest an extra $2 billion to expand its RTP facilities, focusing on AI-driven manufacturing and late-stage ...

Biogen Inc. has announced a $2 billion investment to expand its manufacturing capabilities at Research Triangle Park (RTP), ...

We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Biogen Inc. stands sixth on our list among the most ...

One of North Carolina's largest biotechnology companies is expanding its operations with a $2 billion investment.

One of North Carolina’s largest life sciences companies, Biogen Inc. (Nasdaq BIIB), is celebrating its 30th anniversary in the state by announcing that it intends to invest an additional $2 billion at ...

(Reuters) -Drugmaker Biogen said on Monday it will invest an additional $2 billion in its existing manufacturing footprint in ...